Neuren Pharmaceuticals
NEU.AX
#5445
Rank
HK$7.96 B
Marketcap
HK$62.19
Share price
5.42%
Change (1 day)
-35.62%
Change (1 year)

Earnings for Neuren Pharmaceuticals (NEU.AX)

Earnings in 2024: HK$0.88 Billion

According to Neuren Pharmaceuticals's latest financial reports the company's current earnings are HK$0.13 Billion. In 2024 the company made an earning of HK$0.88 Billion a decrease over its 2023 earnings that were of HK$1.08 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neuren Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024HK$0.88 B-18.58%
2023HK$1.08 B111519.63%
2022HK$0.97 M-102.22%
2021-HK$43.8 Million-20.06%
2020-HK$54.79 Million-6.65%
2019-HK$58.69 Million-449.8%
2018HK$16.77 M-213.69%
2017-HK$14.76 Million-80.94%
2016-HK$77.42 Million-3.07%
2015-HK$79.87 Million51.42%
2014-HK$52.75 Million-32.7%
2013-HK$78.37 Million87.47%
2012-HK$41.81 Million10.96%
2011-HK$37.68 Million-4.11%
2010-HK$39.29 Million21025.61%
2009-HK$0.19 Million-99.78%
2008-HK$83.98 Million1.99%
2007-HK$82.35 Million33.24%
2006-HK$61.81 Million31.45%
2005-HK$47.02 Million37.67%
2004-HK$34.15 Million4.98%
2003-HK$32.54 Million36.5%
2002-HK$23.84 Million